Belite Bio, Inc (BLTE) EBITDA
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$84.21M | (m) | (m) | (m) | $71.00K | -$36.99M | (m) | $45.38M | $38.83M | $0.00 |
| 2024-12-31 | Reported | (m) | -$40.00M | (m) | (m) | (m) | $116.00K | -$29.23M | (m) | $29.94M | $10.06M | $6.00K |
| 2023-12-31 | Reported | (m) | -$31.67M | (m) | (m) | (m) | $63.00K | -$29.84M | (m) | $24.84M | $6.82M | $9.00K |
| 2022-12-31 | Reported | (m) | -$12.82M | (m) | (m) | (m) | $394.00K | -$11.46M | (m) | $8.87M | (m) | (m) |
| 2021-12-31 | Reported | (m) | -$9.80M | (m) | (m) | (m) | $74.00K | -$7.47M | (m) | $7.42M | (m) | (m) |
| 2020-12-31 | Reported | (m) | -$5.74M | (m) | (m) | (m) | (m) | -$4.44M | (m) | $3.69M | (m) | $1.00K |